Skip to main content

Advertisement

SpringerLink
Log in

Are estrogen receptors alpha detectable in normal and abnormal thyroid tissue?

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

The aims of this study is to evaluate the presence of estrogen receptors alpha (ERα) in thyroid lesions and to assess the practicality of this test in view of numerous disagreements on the subject. Immunohistochemical stains were performed for ERα, for the evaluation of immunoreactivity in 296 pathological thyroid tissue samples. We evaluated the intensity of the nuclear and cytoplasmatic staining and the spread of the stain over the sample. Thirty cases of the breast cancer served as a control group. None of the histological thyroid samples showed immunoreactivity for ERα. No difference was found between the various lesions in regard to this absence. The ERα rate of expression in the breast cancer samples was 60%. The ERα is undetectable in the histological samples of benign and malignant thyroid lesions. Further investigation is necessary in the laboratory immunohistochemical workup in order to exclude a possibility of non-specific staining.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Miki H, Oshimi K, Mrimoto T, Monden Y (1990) Sex hormone receptors in human thyroid tissues. Cancer 66:1759–1762

    Article  CAS  PubMed  Google Scholar 

  2. Henderson BE, Ross RK, Pike MC, Casagrande JT (1982) Endogenous hormones as a major factor in human cancer. Cancer Res 42:3232–3239

    CAS  PubMed  Google Scholar 

  3. Samaan NA, Maheshwari YK, Nader S et al (1983) Impact of therapy for differentiated carcinoma of the thyroid. J Clin Endocrinol Metab 56:1136–1138

    Article  Google Scholar 

  4. Lewy-Trenda I (2002) Estrogen and progesterone receptors in neoplastic and non neoplastic thyroid lesions. Pol J Pathol 53:67–72

    CAS  PubMed  Google Scholar 

  5. Greene GL, Nolan C, Engler JP, Jensen EV (1980) Monoclonal antibodies to human estrogen receptor. Proc Natl Acad Sci USA 77(9):5115–5119

    Article  CAS  PubMed  Google Scholar 

  6. Garancis JC, Miller LS, Tomita JT, Tieu TM, Clowry LJ Jr (1983) Immunoperoxidase localization of estrogen receptors in human breast carcinoma. Cancer Detect Prev 6(1–2):235–239

    CAS  PubMed  Google Scholar 

  7. Gilbert C (1997) Major human cancers are preventable: physiological stimuli induce a dopamine-thyroid-immune efficient mechanism. Eur J Cancer Prev 6(3):269–276

    CAS  PubMed  Google Scholar 

  8. Sonoo H, Kurebayashi J (2001) Endocrine therapy for advanced or recurrent breast cancer. Gan To Kagaku Ryoho 28(7):909–916

    CAS  PubMed  Google Scholar 

  9. Mosselman S, Polman J, Dijkema R (1996) ERβ: Identification and characterization of a novel human estrogen receptor. FEBS Lett 392(1):49–53

    Article  CAS  PubMed  Google Scholar 

  10. van Hoeven KH, Menendez-Botet CJ, Strong EW, Huvos AG (1993) Estrogen and progesterone receptor content in human thyroid disease. Am J Clin Pathol 99(2):175–181

    PubMed  Google Scholar 

  11. Hiasa Y, Nishioka H, Kitahori Y et al (1993) Immunohistochemical analysis of estrogen receptors in 313 paraffin section cases of human thyroid tissue. Oncology 50(2):132–136

    Article  CAS  PubMed  Google Scholar 

  12. Yane K, Kitahori Y, Konishi N et al (1994) Expression of estrogen receptor in human thyroid neoplasm. Cancer Lett 84:59–66

    Article  CAS  PubMed  Google Scholar 

  13. Giani C, Campani D, De Negri F et al (1993) Interference of thyroperoxidase on immuno-cytochemical determination of steroid receptors in thyroid tissue. J Endocrinol Invest 16(1):37–43

    CAS  PubMed  Google Scholar 

  14. Candanedo-Gonzalez FA, Gamboa-Dominguez A (2007) Postmenopause is associated with recurrence of differentiated papillary thyroid carcinoma. Med Hypotheses 69(1):209–213

    Article  PubMed  Google Scholar 

  15. Diaz NM, Mazoujian G, Wick MR (1991) Estrogen-receptor protein in thyroid neoplasms. An Immunohistochemical analysis of papillary carcinoma, follicular carcinoma, and follicular adenoma. Arch Pathol Lab Med 115(12):1203–1207

    CAS  PubMed  Google Scholar 

  16. Katoh AK, Stemmler N, Specht S, D’Amico F (1997) Immunoperoxidase staining for estrogen and progesterone receptors in archival formalin fixed, paraffin embedded breast carcinomas after microwave antigen retrieval. Biotech Histochem 72(6):291–298

    Article  CAS  PubMed  Google Scholar 

  17. Stoss F, Spona J (1987) Steroid hormone receptors in struma. Wien Klin Wochenschr 99(13):460–461

    CAS  PubMed  Google Scholar 

  18. Hampl R, Nĕmec J, Heresová J, Kimlová I, Stárka L (1985) Estrogen receptors in human goitrous and neoplastic thyroid. Endocrinol Exp 19(4):227–230

    CAS  PubMed  Google Scholar 

  19. Kawabata W, Suzuki T, Moriya T, Fujimori K et al (2003) Estrogen receptors (a and b) and 17b-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and action. Mod Pathol 16:437–444

    Article  PubMed  Google Scholar 

  20. Zeng Q, Chen G, Vlantis A, Tse G, van Hasselt C (2008) The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas. J Pathol 214(4):425–433

    Article  CAS  PubMed  Google Scholar 

  21. Cho MA, Lee MK, Nam KH, Chung WY et al (2007) Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis. J Endocrinol 195(2):255–263

    Article  CAS  PubMed  Google Scholar 

  22. Ceresini G, Morganti S, Graiani V et al (2006) Estrogen receptors (ER)- B but not ER-A is present in thyroid vessels: immunohistochemical evaluation in multinodular goiter and papillary thyroid carcinoma. Thyroid 6:1215–1220

    Article  Google Scholar 

  23. Bléchet C, Lecomte P, De Calan L et al (2007) Expression of sex steroid hormone receptors in C cell hyperplasia and medullary thyroid carcinoma. Virchows Arch 450(4):433–439

    Article  PubMed  Google Scholar 

  24. Kurzon RM, Sternberger LA (1978) Estrogen receptor immunocytochemistry. J Histochem Cytochem 26(10):803–808

    CAS  PubMed  Google Scholar 

  25. Pertschuk LP, Gaetjens E, Carter AC et al (1979) An improved histochemical method for detection of estrogen receptors in mammary cancer. Comparison with biochemical assay. Am J Clin Pathol 71(5):504–508

    CAS  PubMed  Google Scholar 

  26. Goulding H, Pinder S, Cannon P et al (1995) A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. Hum Pathol 26(3):291–294

    Article  CAS  PubMed  Google Scholar 

  27. Harvey JM, Clark GM, Osborne CK, Allred DC (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17(5):1474–1481

    CAS  PubMed  Google Scholar 

  28. Rhodes A, Jasani B, Barnes DM et al (2000) Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. J Clin Pathol 53(2):125–130

    Article  CAS  PubMed  Google Scholar 

  29. Huang Z, Zhu W, Szekeres G, Xia H (2005) Development of new rabbit monoclonal antibody to estrogen receptor: immunohistochemical assessment on formalin-fixed, paraffin-embedded tissue sections. Appl Immunohistochem Mol Morphol 13(1):91–95

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology-Head and Neck Surgery, Assaf HaRofeh Medical Center affiliated to the Sackler Medical School, Tel-Aviv University, Zerifin, Israel

    Michael Vaiman, Youlian Olevson & Alex Kessler

  2. Department of Histology and Pathology, Assaf HaRofeh Medical Center affiliated to the Sackler Medical School, Tel-Aviv University, Zerifin, Israel

    Judith Sandbank, Liliana Habler & Sergei Zehavi

  3. 33 Shapira Str, Zerifin, 59561, Bat Yam, Israel

    Michael Vaiman

Authors
  1. Michael Vaiman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Youlian Olevson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Judith Sandbank
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Liliana Habler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sergei Zehavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alex Kessler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Vaiman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vaiman, M., Olevson, Y., Sandbank, J. et al. Are estrogen receptors alpha detectable in normal and abnormal thyroid tissue?. Eur Arch Otorhinolaryngol 267, 1753–1757 (2010). https://doi.org/10.1007/s00405-010-1269-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-010-1269-0

Keywords

Search

Navigation